Systems Oncology

1 follower


Systems Oncology is developing a new class of multimodal RNA therapeutics that can simultaneously silence numerous disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance.

Industries

Employees

11-50

Links

Org chart

Spyro Mousses
Co-Founder & Chief Executive Officer

Spyro Mousses

Collapse
Daniel D. Von Hoff
Co-Founder & Chief Clinical Strategist
Marvin O’Ketch
Associate Director, Immunobiology
David Lee
Lab Manager & Senior Scientist
Lizette Castano
Research Associate II
Robert G. Petit II
Drug Development Advisor
Katy Marhenke
Director, Business Development Operations